Albendazole is a broad-spectrum anthelmintic belonging to the benzimidazoles, effective against roundworms and, depending on the dose, also against some tapeworms (e.g. Moniezia spp) and a few trematodes (e.g. Fasciola hepatica adults). It is completely ineffective against external parasites. Oral administration is the rule.

It is used massively in livestock (manily in drenches and feed additives), and only moderately in pets (often in tablets, pills, etc. or oral suspensions). There are hundreds of generic brands worldwide, also in mixtures with other anthelmintics.

Albendazole is not used against agricultural or household pests.

The table below indicates some usual dosing recommendations for albendazole issued by manufacturers or documented in the scientific literature. They may not be approved in some countries.

Dosing recommendations for ALBENDAZOLE
DOGS
Delivery Parasites Dose (against albendazole-susceptible parasites)
Oral Toxocara canis, Ancylostoma spp 12.5-30.6 mg/kg
Oral Toxocara canis, Ancylostoma spp Reactivated somatic larvae: 100 mg/kg/day from day 30 of gestation till birth
Oral Strongyloides stercoralis 100 mg/animal/2x/day x 3 days
Oral Capillaria plica 50 mg/kg/12 hours x 10-14 days
Oral Filaroides hirthi 50 mg/kg 2x/day x 5 days, rep after 21 days
Oral Filaroides osleri 25 mg/kg 2x/day x 5 days
Oral Paragonimus kellicotti 50 mg/kg/day x 21 days
Oral Giardia spp 25 mg/kg 2x/day x 4 days
CATS
Delivery Parasites Dose (against albendazole-susceptible parasites)
Oral Capillaria plica 50 mg/kg/day x 10-14 days
Oral Paragonimus kellicotti  50 mg/kg/day x 21 days 
CATTLE
Delivery Parasites Dose (against albendazole-susceptible parasites)
Oral Roundworms 5-10 mg/kg
Oral Ostertagia ostertagi inhibited larvae 10 mg/kg
Oral Dictyocaulus viviparus 3.8-10 mg/kg
Oral Fasciola hepatica, adults 10-15 mg/kg
Oral Fascioloides magna 15-25 mg/kg
Oral Tapeworms (e.g. Moniezia spp) 10 mg/kg 
Oral Cysticercus bovis (Taenia saginata) 50 mg/kg
Oral Giardia spp 20 mg/kg/day x 3 days
SHEEP  
Delivery Parasites  Dose (against albendazole-susceptible parasites)
Oral Roundworms  7.5 mg/kg
Oral  Dictyocaulus filaria 3.8 mg/kg 
Oral  Trichuris spp  10 mg/kg 
Oral Fasciola hepatica, adults 7.5-15 mg/kg
Oral Dicrocoelium dendriticum 11-20 mg/kg
Oral Moniezia spp 3.8-10 mg/kg
GOATS
Delivery Parasites  Dose (against albendazole-susceptible parasites)
Oral Roundworms  7.5 mg/kg
Oral Dictyocaulus filaria 3.8 mg/kg
Oral Fasciola hepatica, adults 15 mg/kg 
Oral Fascioloides magna 15 mg/kg  
SWINE 
Delivery Parasites  Dose (against albendazole-susceptible parasites)
Oral Roundworms, gastrointestinal 5-10 mg/kg 
Oral Metastrongylus apri 10-30 ppm in feed x 5 days
HORSES
Delivery Parasites  Dose (against albendazole-susceptible parasites)
Oral Strongylus equinus Migrating larvae: 50 mg/kg 2x/day x 2 days
Oral Cystic echinococcosis 4-8 mg/kg 2x/day, x 30 days
SOUTH AMERICAN CAMELIDS
Delivery Parasites  Dose (against albendazole-susceptible parasites)
Oral Roundworms 10 mg/kg
Oral Tapeworms 10 mg/kg
Oral Fascioloides magna 15 mg/kg

DISCLAIMER: Liability is denied for any possible damage or harm to persons, animals or any other goods that could follow the transmission or use of the information, data or recommendations in this site by any site visitor or third parties.

In ruminants, a 50% reduction of the diet 36 prior and 8 hours after treatment slows down the passage through the stomach, which increases the bioavailability of albendazole and its metabolites and consequently its efficacy against gastrointestinal parasites.

In carnivores (incl. dogs and cats) delivery with the food increases the bioavailability of all benzimidazoles resulting in a better efficacy.

Benzimidazoles have almost no residual effect, i.e. they kill the parasites during a few hours after treatment but offer no significant protection against re-infestation.

Unfortunately, resistance of gastrointestinal roundworms to all benzimidazoles in sheep, goats, cattle and horses is a major problem in numerous countries. Not so yet in pets, swine or poultry.

Dosing recommendations for antiparasitics depend on national regulations. National regulatory authorities determine whether a product is approved for a given indication, i.e. use on a particular host at a specific dose and against a specific parasiteCheck the labels of the products available in your country for specific information on approved indications


  • Click here to view the technical summary of this active ingredient
  • Click here to view the safety summary of this active ingredient
  • Click here to view the list of all technical summaries of antiparasitic active ingredients in this site.